We are pleased to announce that our CEO, Dr. Keith Martin will attend the 16th edition of Bio€quity Europe in Vienna, Austria. Keith will be presenting the Apitope portfolio during the biotech company presentation sessions at 10:00 in Ballroom 1 on Wednesday, May 20th. For more information about the conference and the meeting schedule, please…Details
Apitope will be attending the 11th Knowledge for Growth convention on May 21st in Ghent, Belgium. Apitope’s research director, Dr. Lotta Jansson will be presenting a poster titled: “Prevention of FVIII inhibitor formation by ATX-F8-117 in humanized HLA-DRB1*1501 mice” and Apitope scientist, Dr. Kathleen Vrolix will be presenting the poster titled: “Antigen-specific peptide therapy prevents…Details
We are pleased to announce that our CEO, Dr. Keith Martin will be speaking at the 13th consecutive event organised by LSP (Life Science Partners), the BioCapital Europe 2015 conference. The conference will be held at the Sofitel Legend The Grand Amsterdam hotel on the 26th of March. Keith is looking forward to meeting with you…Details
Our commercial director, Hayley French and business development manager, Raf Roelands will be attending the 9th Annual edition of the Bio-Europe Spring® conference, held March 9th – 11th in Paris, France. Hayley and Raf will be happy to meet with you to discuss potential partnerships. For more information on the conference, please visit the Bio-Europe Spring…Details
Our research director, Dr. Lotta Jansson will be speaking at the 5th annual immunotherapy forum which is being organized in Washington DC from January 26th – 28th. Lotta will be speaking about “Antigen specific immunotherapy – immune tolerance induced by peptide apitopes” on January 28th from 12h50h – 13h10. Furthermore, she will be participating in…Details
Our commercial director and general counsel, Dr. Hayley French will be participating in the 20th annual Bio-Europe partnering conference held November 3rd – 5th in Frankfurt, Germany. Hayley is looking forward to meeting with you to discuss potential partnerships.
For more information, please visit the conference website:http://www.ebdgroup.com/bioeurope/index.php
Our commercial director and general counsel, Dr. Hayley French will be presenting at BioPharm America™.
Hayley will give a presentation on the current activities of Apitope on September 23rd at 3PM and will be taking part in the partnering sessions.
For further information, please visit the conference website: http://www.ebdgroup.com/bpa/index.php
Prof. David Wraith, Apitope’s founder and CSO, will be presenting at the SMi Immunogenicity Conference, held in London, UK. David will be talking about Inducing Immunological Tolerance – Reviewing The Flip Side on July 14th from 11:40am until 12:20pm.
For more information, please visit the conference website: www.smi-online.co.uk/pharmaceuticals/uk/conference/Immunogenicity